Pterostilbene inhibits non-small cell lung cancer progression by activating the STING pathway and enhancing antitumor immune response.

From day 15 of treatment onward, we observed a notable trend of tumor suppression in the PTE treatment group ( Figure 7B ), accompanied by significant reductions in tumor volume ( Figures 7B, C ) and overall tumor weight ( Figure 7D ).

also in 2,162 other papers